[Hepatological news (2). The twilight of immunosuppression in hepatitis B--the dawn of new methods?].
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D005260:Female; D006509:Hepatitis B / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007978:Levamisole / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D013949:Thymus Extracts / Q000627:therapeutic use; D014740:Vidarabine / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D000305:Adrenal Cortex Hormones; D007166:Immunosuppressive Agents; D013949:Thymus Extracts; D007978:Levamisole; D014740:Vidarabine
Wiadomości hepatologiczne (2). Zmierzch immunosupresji w zakazeniach wirusem B--świt nowych metod?